Skip to content
2000
Volume 10, Issue 6
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Camptothecin (CPT) and its hydroxycamptothecin analogs are fluorescent compounds exhibiting strong anticancer properties. They exist in two forms: active lactone and inactive carboxylate. The deactivation proceeds via hydrolysis in neutral and base solutions. A serious limitation to the clinical application of CPT is the strong affinity of its carboxylate form to human serum albumin (HSA) which destabilizes its active lactone form. However, binding to membranes in blood improves the stability of the lactone form of CPT and its analogs. A high-throughput screening assay based on the steady-state fluorescence anisotropy method was used to determine the protein- and membrane-binding properties of 10-hydroxycamptothecin (10-OH-CPT), 7-ethyl-10-hydroxycamptothecin (SN-38) and 7-tertbutyldimethylsil- 10-hydroxycamptothecin (DB-67). The relative affinities of hydroxycamptothecins to HSA and model membranes in the form of DMPC liposomes were determined, and DB-67 exhibited the most desirable properties including the highest affinity to membranes in its lactone form and low affinity to HSA in its carboxylate form.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/138620707781996420
2007-07-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/138620707781996420
Loading

  • Article Type:
    Research Article
Keyword(s): Camptothecin; fluorescence anisotropy; human serum albumin (HSA); membranes
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test